Skip to main content

885 publications

Name Date Type Actions

Monthly information regarding the total number of voting rights – October 2024


As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »
 

Voting rights

Buyback programs - October 2024

Monthly communication regarding buyback programs 

Liquidity contract , Description of buyback programs

Sales at end September 2024

At the end of September 2024, Vetoquinol sales totaled €398 million, up +1.6% on a reported basis and +1.8% at constant exchange rates.

Public releases

Buyback programs - September 2024

Monthly communication regarding buyback programs 

Description of buyback programs

Monthly information regarding the total number of voting rights – September 2024

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

Voting rights

2024 half-year Results

Sales: €264m (+3.2% as reported)
Essentials products sales: €160m (+6.0% of Group sales)
Net income - Group share: €24m (9.0% of sales)
EBITDA*: €45m (17% of sales)
Cash-flow generation: €27m

Public releases

2024 Half-Year Results slideshow

Contents
1. First semester 2024 results
2. Conclusion and outlook

Half Year Report

Rapport financier semestriel 2024 (French)

Rapport financier semestriel 2024 (French)

Half Year Report

Buyback programs - August 2024

Monthly communication regarding buyback programs 

Description of buyback programs

Monthly information regarding the total number of voting rights – August 2024

Voting rights